<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Medications for treatment of symptomatic hemorrhoids in nonpregnant adults*</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Medications for treatment of symptomatic hemorrhoids in nonpregnant adults*</h1>
<div class="graphic"><div class="figure"><div class="ttl">Medications for treatment of symptomatic hemorrhoids in nonpregnant adults*</div><div class="cntnt"><table cellspacing="0"><colgroup span="3" width="33%"></colgroup> <tbody> <tr> <td class="subtitle1">Drug</td> <td class="subtitle1">Dose</td> <td class="subtitle1">Role and precautions</td> </tr> <tr> <td class="subtitle2_left" colspan="3">Treatment</td> </tr> <tr> <td class="subtitle3_left" colspan="3">Anesthetics, local</td> </tr> <tr> <td class="indent2">Dibucaine 1% rectal ointment</td> <td>Sparingly as needed up to four times per day</td> <td rowspan="2"> <ul> <li>Temporary relief of acute pain and pruritus.</li> <li>Intended for short-term, intermittent use.</li> <li>For external use only. Local burning is common.</li> <li>Systemic absorption is variable.</li> </ul> </td> </tr> <tr> <td class="indent2">Pramoxine 1% rectal foam</td> <td>As needed up to five times per day</td> </tr> <tr> <td class="subtitle3_left" colspan="3">Astringent and protectants, topical</td> </tr> <tr> <td class="indent2">Witch hazel pads</td> <td>As needed up to six times per day or after each bowel movement</td> <td rowspan="2"> <ul> <li>Provides temporary relief of pruritus and irritation.</li> <li>Witch hazel may dry secretions and tighten tissues.</li> <li>Zinc oxide has protectant, astringent, and antiseptic properties.</li> <li>Well tolerated; rare allergy.</li> </ul> </td> </tr> <tr> <td class="indent2">Zinc oxide topical paste</td> <td>As needed</td> </tr> <tr> <td class="subtitle3_left" colspan="3">Corticosteroids, topical</td> </tr> <tr> <td class="indent2">Hydrocortisone rectal cream 1 to 2.5%</td> <td>Rectal cream: Apply sparingly as needed up to two times per day</td> <td rowspan="2"> <ul> <li>Provides local anti-inflammatory and analgesic effect.</li> <li>For intermittent short-term use (ie, no more than 7 days) due to risk of mucosal thinning.</li> <li>Avoid in persons with local infection.</li> <li>Variable systemic absorption; caution in pregnancy.</li> </ul> </td> </tr> <tr> <td class="indent2">Hydrocortisone rectal suppository 25 to 30 mg</td> <td>Suppository: 1 suppository per rectum as needed up to two times per day</td> </tr> <tr> <td class="subtitle3_left" colspan="3">Vasoactive agents, topical</td> </tr> <tr> <td class="indent2">Nitroglycerin (glyceryl trinitrate) 0.2 to 0.5% ointment*</td> <td>Apply pea-sized amount two times per day</td> <td> <ul> <li>Potential option for managing pain associated with anal sphincter spasm or thrombosed external hemorrhoids.</li> <li>Systemic adverse effects (eg, headache) are common.</li> </ul> </td> </tr> <tr> <td class="indent2">Phenylephrine 0.25% rectal ointment or suppository (eg, Preparation-H)</td> <td> <p>Ointment: Apply as needed up to four times per day</p> Suppository: 1 suppository per rectum as needed up to four times per day</td> <td> <ul> <li>Frequent choice for temporary relief of acute symptoms (ie, bleeding or pain on defecation).</li> <li>Well tolerated; rare systemic effects.</li> <li>Ointment may be applied externally or inserted per rectum using applicator.</li> </ul> </td> </tr> <tr> <td class="subtitle3_left" colspan="3">Combination anesthetic and corticosteroid, topical</td> </tr> <tr> <td class="indent2"> <p>Lidocaine and hydrocortisone cream (eg, lidocaine-hydrocortisone 2%-2%, 3%-0.5%, and 3%-1%)<sup>¶</sup></p> Lidocaine and hydrocortisone gel (eg, lidocaine-hydrocortisone 2.8%-0.55% and 3%-2.5%)<sup>¶</sup></td> <td>Cream or gel: Apply as needed up to two times per day</td> <td> <ul> <li>Temporary relief of acute pain and pruritus; local anti-inflammatory effect.</li> <li>For intermittent short-term use (ie, no more than 7 days) due to risk of mucosal thinning and contact dermatitis.</li> <li>May be applied externally or inserted per rectum using applicator.</li> <li>Avoid in persons with local infection.</li> <li>Variable systemic absorption; caution in pregnancy.</li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="3">Prevention</td> </tr> <tr> <td class="subtitle3_left" colspan="3">Bulk-forming laxatives (ie, fiber supplements), oral<sup>Δ</sup></td> </tr> <tr> <td class="indent2">Methylcellulose</td> <td>Initially 1 tablespoon (≅2 grams fiber) or 4 caplets (500 mg fiber per caplet) once per day; may increase to 1 tablespoon or 4 caplets three times per day</td> <td rowspan="4"> <ul> <li>Reduces bleeding and possibly symptoms in nonprolapsing hemorrhoids; gradual onset of effect over 6 weeks or more.</li> <li>Useful in patients with inadequate dietary fiber intake who may be at risk for constipation or diarrhea.</li> <li>Adequate oral fluid intake required; administer with 180 to 360 mL (6 to 12 ounces) water or fruit juice.</li> <li>Gradually increase dose as needed to minimize gas and bloating.</li> <li>Do not administer within 1 hour of other medications.</li> </ul> </td> </tr> <tr> <td class="indent2">Polycarbophil</td> <td>Initially 1 to 2 tablets (500 mg fiber per tablet) per day; may increase to 2 to 4 tablets per day</td> </tr> <tr> <td class="indent2">Psyllium</td> <td>Initially 1 tablespoon (≅3.5 grams fiber) once per day; may increase to 1 tablespoon three times per day</td> </tr> <tr> <td class="indent2">Wheat dextrin</td> <td>Initially 1 caplet (1 gram fiber) or 1 teaspoonful (1.5 grams fiber) per day; may increase to 3 caplets or 2 teaspoonfuls three times per day</td> </tr> <tr> <td class="subtitle3_left" colspan="3">Stool softeners, oral</td> </tr> <tr> <td class="indent2">Docusate sodium</td> <td>100 mg orally two times per day</td> <td> <ul> <li>Decreases straining.</li> <li>Well tolerated. Use lower dose if administered with another laxative.</li> </ul> </td> </tr> </tbody></table></div><div class="graphic_lgnd"><ul>
<li>Medical therapy for internal hemorrhoids may be useful for controlling symptoms in lower-grade disease and acute bleeding in higher-grade hemorrhoids pending definitive therapy (eg, banding, sclerotherapy, cryotherapy, or surgery).</li>
<li>Before applying topical preparations, the affected area should be gently cleansed and allowed to dry.</li>
<li>A large number of topical preparations are available in addition to those listed in the table; evidence of efficacy for most is lacking.</li>
<li>Medications in this table are available without a prescription (over the counter) in the United States, except where noted.</li>
</ul></div><div class="graphic_footnotes"><p>* Nitroglycerin 0.4% rectal ointment is available as a prescription product in the United States and other countries and has been studied for anal fissure. Other strengths of nitroglycerin ointment shown in the table are not commercially available products in the United States.</p>
<p>¶ Available only as a prescription product in the United States.</p>
Δ A high-fiber diet and increased fluid intake is recommended in most patients with hemorrhoidal disease to soften stools and prevent the need for straining. Patients should also be counseled to avoid prolonged sitting or straining on the toilet, on improving anal hygiene, and on avoiding triggers for constipation or diarrhea. Recommendations on dietary fiber intake are provided elsewhere in UpToDate.</div><div class="graphic_reference">Prepared with data from:
<ol>
<li>Hall JF. Modern management of hemorrhoidal disease. Gastroenterol Clin N Am 2013; 42:759.</li>
<li>Lorsiriwat V. Hemorrhoids: From basic pathophysiology to clinical management. World J Gastroenterol 2012; 18:2009.</li>
<li>Madoff RD, Fleshman JW. American Gastroenterological Association technical review on the diagnosis and treatment of hemorrhoids. Gastroenterology 2004; 126:1463.</li>
</ol></div><div id="graphicVersion">Graphic 103146 Version 9.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
